Johnson & Johnson is a pharmaceutical, medical device, and consumer packaged products company that was founded in 1886. As of 2020, this American multinational firm has over 132,000 workers and is based in New Brunswick, New Jersey, USA. It has over 250 subsidiaries in over 60 countries.

Johnson & Johnson has ranked first in revenue among the major biotech businesses since 2012. In 2019, the corporation made $82.059 billion in sales. Johnson & Johnson posted first-quarter sales of $20.7 billion on April 14, 2020, representing a robust 3.3 percent increase. The corporation made $18.3 billion and $21.1 billion in the second and third quarters of 2020, respectively. The impact of COVID-19 was reflected in a 10.8% drop in revenue in the second quarter. The strength of Johnson & Johnson's business model, the quality and breadth of their portfolio, and the company's constant commitment toward innovation are reflected in the company's 1.7 percent gain in the third-quarter financial report for 2020. Johnson & Johnson made $60.1 billion in sales in the first, second, and third quarters of 2020.

Amazing things are possible thanks to the mix of modern technology and their experience. J&J's consumer business is developing digital tools to help customers keep track of their skin's health. Medical device engineers are 3D printing prosthetic joints that are tailored for each patient, while pharmaceutical researchers are using AI to develop life-saving medications. Consider what the rest of their 134,000-strong staff at 260 firms in more than 60 countries is achieving. In today's environment, they redefine what it means to be a large corporation.

Founded: 1886

Headquarters: New Brunswick, NJ

Market Cap: 434.40B USD

Website: https://www.jnj.com/

Pfizer, based in New York City, is an American global pharmaceutical firm. Pfizer works via two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). It is one of the world's major pharmaceutical businesses. Pfizer is a pharmaceutical company that makes and develops vaccines and drugs for a variety of medical fields, including immunology, cardiology, endocrinology, and neurology.

Pfizer had yearly revenues of $51.8 billion in 2019, and has been the second-largest pharmaceutical firm in the United States for the previous four years, behind Johnson & Johnson. Pfizer's first-quarter 2020 revenues of $12.0 billion and second-quarter 2020 revenues of $11.8 billion were down 7% and 9%, respectively, due to operational declines. COVID-19 had an estimated unfavorable impact of approximately $500 million, or 4%, on the company's third-quarter 2020 revenues of $12.1 billion, primarily driven by lower demand for certain products in China and unfavorable disruptions to patient wellness visits in the United States, which negatively impacted prescribing patterns for certain products, partially offset by increased adult uptake for Prevenar 13 in certain international markets as a result of a regulatory change.

Founded: 1849
Headquarters: New York, New York, United States
Market Cap: 278.82B USD
Website: https://www.pfizer.com/

Merck & Co. was founded in 1891 and is now one of the world's largest pharmaceutical corporations. This major American multinational pharmaceutical firm, based in Kenilworth, New Jersey, is noted for its autoimmune disorders, hypercholesterolemia, type 2 diabetes, cancer, and other illnesses and medical problems, as well as animal health products.

Merck had yearly sales of 46.8 billion dollars in 2019. In the first quarter of 2020, the firm posted worldwide revenues of $12.1 billion, an increase of 11%. This was followed by $10.9 billion in global sales in the second quarter and $12.6 billion in global sales in the third quarter of 2020. Global sales fell 8% in the second quarter of 2019 compared to the same period last year, owing to the unfavorable impact of COVID-19. The third quarter of 2020 saw a 1% increase in worldwide sales.

Merck's sales increased by $35.6 billion from the first to the third quarters of 2020. The business expects full-year sales in 2020 to range between $47.6 billion and $48.6 billion, excluding a 1.5 percent negative effect from foreign exchange.

Founded: 1891

HeadquartersKenilworth, NJ

Market Cap: 212.18B USD

Website: https://www.merck.com/

AbbVie is a publicly listed biopharmaceutical firm based in Lake Bluff, Illinois, that was created in 2013 as a spin-off of Abbott Laboratories. This firm creates, manufactures, and distributes biopharmaceuticals and small molecule medications.

AbbVie, another of the world's largest pharmaceutical corporations, was formed after Abbot Laboratories was divided into two businesses. Employees at Abbvie have worked on a variety of pharmaceutical projects, including exploring new ways to cure ailments like Crohn's disease, GARP, and cystic fibrosis. AbbVie Inc. made $33.27 billion in revenue in 2019.

The firm produced $8.619 billion in the first quarter of 2020, up 10.1 percent on a reported basis and 10.7 percent operationally, thanks to a 240 basis point stocking advantage connected to the COVID-19 pandemic. On a reported basis, second-quarter 2020 sales of $10.425 billion and third-quarter 2020 revenue of $12.902 billion represented a 26.3 percent rise and a 52.16 percent increase year-over-year, respectively, including a partial quarter of Allergan and COVID-19 pandemic effects. Abbvie made $31.95 billion in sales in the first three quarters of 2020.

Founded: January 1, 2013
Headquarters: Lake Bluff, Illinois, United States
Market Cap: 206.79B USD
Website: https://www.abbvie.com/

Bristol-Myers Squibb is a pharmaceutical business based in New York City. Edward Robinson Squibb, who was well-known at the time for his zealous advocacy for greater quality control standards in medicine, formed Myers Squibb in the mid-1800s. The corporation is now one among the world's largest pharmaceutical companies, with a market capitalization of $98.2 billion last year.

Bristol Myers Squibb is a multinational biopharmaceutical firm dedicated to improving the lives of people throughout the globe by developing genuinely revolutionary medications that help them overcome serious diseases. Bristol Myers Squibb manufactures prescription medications and biologics for cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and mental disorders, among other therapeutic areas.

Bristol Myers Squibb made $26.15 billion in sales in 2019. Bristol-Myers Squibb announced a $10.8 billion first-quarter 2020 profit. Revenues of $10.1 billion in the second quarter of 2020 represented a 61 percent gain on a reported basis, or a 63 percent increase when adjusted for foreign exchange. The impact of the Celgene purchase, which was finalized on November 20, 2019, was the primary driver of the rise. Bristol Myers Squibb made $10.5 billion in revenue in the third quarter of 2020.

Founded: 1960
Headquarters: Lawrence Township, NJ
Market Cap: 131.91B USD
Website: https://www.bms.com/

Abbot Laboratories is the second of two firms formed by the 2013 split of the original Abbot Laboratories. Abbot Laboratories is responsible for the diagnostic and medical technology side of the company, while AbbVie is responsible for pharmaceutical research.

Abbot Laboratories is ranked number six on our list of the top ten pharmaceutical businesses in the United States. Abbott Laboratories, founded in 1888 and headquartered at the Abbott Park Business Center in Lake Bluff, Illinois, sells medical equipment, diagnostics, branded generic drugs, and nutritional items. HIV, hepatitis, cancer, heart failure, and metabolic disorders are among the conditions for which Abbott's products are used to diagnose and monitor.

Abbot Laboratories had a revenue of $31.9 billion in 2019 and employed roughly 107,000 people in December of the same year. Abbot's worldwide sales of $7.7 billion in the first quarter of 2020 climbed 2.5 percent on a reported basis and 4.3 percent organically. The company's worldwide sales of $7.3 billion in the second quarter of 2020 fell 8.2 percent on a reported basis and 5.4 percent organically, excluding the impact of foreign exchange. Global sales of $8.9 billion in the third quarter of 2020 climbed 9.6% on a reported basis and 10.6% on an organic basis, excluding the impact of foreign exchange.

Founded: 1888

Headquarters: Chicago, Illinois, United States

Market cap: 227.14B USD

Website: https://www.abbott.com/

Amgen was founded in Thousand Oaks, California in 1980 under the name Applied Molecular Genetics Inc. This American multinational biopharmaceutical firm is currently one of the world's largest independent biotechnology enterprises.

Amgen made $23.4 billion in sales in 2019. The corporation produced $6.2 billion in sales in the first quarter of 2020, an increase of 11% over the same period last year. Despite the impact of the COVID-19 pandemic, total revenues grew 6% to $6.2 billion in the second quarter of 2019, compared to the same period last year. Higher unit demand countered lower net selling prices in the second quarter of 2020, resulting in an increase. In compared to the third quarter of 2019, total sales climbed by 12% to $6.4 billion, owing to better volume growth, which was largely offset by lower net selling prices and the consequences of the COVID-19 pandemic.

Founded: 1978

Headquarters: Cambridge, Massachusetts, United States

Market cap: 119.07B USD

Website: https://www.amgen.com/

Gilead Sciences, Inc., based in Foster City, California, is an American biopharmaceutical business. Gilead Sciences is a global company with operations across three continents: North America, Europe, and Australia.

After purchasing two smaller pharma businesses that focused on pulmonary illnesses treatment, the international biopharmaceutical company increased its product range after focusing extensively on antiviral medications used in the treatment of HIV, hepatitis B, hepatitis C, and influenza.

Gilead had a sales of $22.1 billion in 2019 and employed 11,800 people. Total revenues for the first quarter of 2020 were $5.5 billion, up 5% from the same period the previous year. This indicates Gilead's continuous success and emphasizes the company's fundamental business's strength. The company's second-quarter 2020 revenue was $5.1 billion, down 10% from $5.7 billion in the same period last year, with Gilead's hepatitis C medicine brand accounting for the majority of the drop. In the third quarter of 2020, total revenues were $6.6 billion, up 17% from $5.6 billion in the same time of 2019.

Founded: June 22, 1987

Headquarters: Foster City, California, United States

Market cap: 84.65B USD

Website: https://www.gilead.com/

The American pharmaceutical firm, known simply as Lilly, was founded in 1876 and is headquartered in Indianapolis, Indiana, with operations in 18 other countries. Penicillin, insulin, and the Salk polio vaccine were all mass-produced by Lilly for the first time.

They are presently the world's leading producer of psychiatric drugs, with Prozac (fluoxetine), Dolophine (methadone), Cymbalta (duloxetine), and Zyprexa (olanzapine) available in over 125 countries.

Lilly made $22.3 billion in sales in 2019. In contrast to the first quarter of 2019, sales of $5.86 billion grew by 15% in the first quarter of 2020. Lilly reported revenues of $5.49 billion and $5.74 billion in the second and third quarters of 2020, respectively. Despite a 2% drop in sales in the second quarter of 2020, Lilly hit many key R&D milestones, including three FDA approvals for novel medicines, favorable phase 3 findings for several key clinical projects, and ongoing progress in the company's effort to create medications for COVID-19 patients.

Founded: 1876

Headquarters: Indianapolis, Indiana

Market Cap: 248.38B USD

Website: https://www.lilly.com/

Biogen Inc. is a global biotechnology corporation headquartered in Massachusetts. The firm, which was founded in 1978 by a small group of visionary scientists, finds, develops, produces, and markets new medicines for patients with neurological and neurodegenerative illnesses all over the world. Biogen also develops and markets biosimilars for sophisticated biologics. Biogen is now one of the world's oldest independent biotechnology businesses.

Biogen made $14.4 billion in sales in 2019. Total sales increased 1% to $3.53 billion in the first quarter of 2020, compared to $3.49 billion in the same quarter last year. The corporation generated around $3.68 billion in the second quarter of 2020, a 2% increase over the second quarter of 2019. Revenue of $3.38 billion in the third quarter of 2020 was down 6% from the third quarter of 2019, including a 1% adverse currency effect.

Founded: 1978

Headquarters: Cambridge, Massachusetts, United States

Market cap: 39.72B USD

Website: https://www.biogen.com/en_us/home.html